Christiane Eickhoff
Free University of Berlin
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Christiane Eickhoff.
Pharmacoepidemiology and Drug Safety | 2012
Christiane Eickhoff; Andrea Hämmerlein; Nina Griese; Martin Schulz
To quantify drug‐related problems (DRPs) in self‐medication (over‐the‐counter [OTC] drug use) identified by community pharmacists (CPs) in Germany at the time the drug is dispensed.
Therapeutic Drug Monitoring | 2010
Andreas Lindauer; Christiane Eickhoff; Charlotte Kloft; Ulrich Jaehde
Introduction: Although for conventional dosing of carboplatin, several strategies are available to individualize the dose based on renal function measurements, such approaches are still rare for high-dose regimens with autologous stem cell support. The purpose of this study was to investigate the influence of patient- and regimen-specific factors on the pharmacokinetics of carboplatin and to compare the performance of different dose individualization strategies (Calvert, Newell, Chatelut, flat dosing, dosing according to body surface area). Patients and Methods: A combined data set with 69 patients from five studies, including 13 pediatric patients, was subject to a population pharmacokinetic analysis using NONMEM. Results: The covariate analysis revealed that carboplatin clearance after high-dose chemotherapy was highly related to creatinine clearance, body height, and infusion duration. After inclusion of these covariates, the population parameter variability of clearance decreased from 53% in the base model to 21% in the final model. We also developed an alternative model that related body weight, instead of height, to clearance by means of allometric scaling. An evaluation of the predictive performance of existing a priori dose individualization strategies revealed that flat dosing is appropriate for adult patients with normal renal function receiving a 1-hour infusion. For a long-term infusion schedule, a dose increase may be necessary. The existing dosing strategies performed poorly for the children in our data set. For this subpopulation, our allometric scaling model may be most appropriate. Conclusion: The two population pharmacokinetic models presented can be applied to estimate individual carboplatin clearance in high-dose chemotherapy based on body weight or height, infusion duration, and creatinine clearance. After prospective evaluation, our models may be suitable for dose adjustments.
Clinical and Applied Thrombosis-Hemostasis | 2012
Carina Hohmann; Christiane Eickhoff; Wolfgang Kaemmerer; Martin Schulz
Despite the existence of antithrombotic guidelines, there is low compliance with these guidelines in clinical practice. Until now pharmacy interns (PIs) have not been involved in this process. The objectives were to involve PIs to evaluate compliance with antithrombotic guidelines for VTE prophylaxis in surgery patients, and in cases of noncompliance to carry out pharmaceutical interventions. The study was conducted in 7 hospitals in Germany involving 27 PIs within the project “Pharmacy interns on the ward” (P-STAT 2). Pharmacy interns determined the thromboembolic risk, documented antithrombotic medication, and checked the compliance with current antithrombotic guidelines. A total of 6491 patients were enrolled; 5695 patients received antithrombotic prophylaxis. Antithrombotic guideline was followed in 77.5% patients. Many patients are not receiving appropriate VTE prophylaxis or heparin bridging regimen despite the fact that evidence-based antithrombotic guidelines are available. Pharmacy interns may play an important role in antithrombotic management.
Patient Preference and Adherence | 2016
Lea Botermann; Katrin Krueger; Christiane Eickhoff; Charlotte Kloft; Martin Schulz
Purpose The Action Plan for Medication Safety by the German Federal Ministry of Health introduced a standardized medication plan (MP), a printable document for the patient. The practical handling needs to be tested before the nationwide implementation in Germany. Therefore, the aims of our study were 1) to develop an instrument to evaluate the usage of the standardized MP, 2) to assess if patients can locate, and 3) understand important information. Moreover, we explored patients’ opinion and suggestions regarding the standardized MP template. Patients and methods We conducted a cross-sectional study to evaluate the practical handling of the standardized MP. We interviewed 40 adult patients in seven community pharmacies in Germany, who took at least five medicines regularly and gave their written informed consent. The interview consisted of questions regarding finding and understanding information provided on a mock-up MP, patients’ opinion and the execution of the information on the MP by filling pill boxes. We eventually developed a new evaluation method to quantify the practical handling of the MP by rating the pill boxes filled by the patients. Results Overall, the participants rated the MP positively. Thirty-nine (98%) participants found important information on a mock-up standardized MP. Patients were questioned to identify if they understood information on medical intake as it relates to meals. In particular, they were questioned about medicine intake “1 hour before a meal”, which 98% (n=39) interpreted correctly, and “during a meal”, which 100% (n=40) interpreted correctly. The less precise advice of “before a meal” was interpreted correctly by 73% (n=29), and only 15% (n=6) correctly interpreted the term “after the meal”. The evaluation of the filled pill boxes resulted in the “Evaluation Tool to test the handling of the Medication Plan” (ET-MP) – a weighted scoring system. Conclusion The standardized MP is clearly arranged, and patients are able to find important information. The findings of this study resulted in minor but important revisions of the standardized MP template. The developed evaluation tool ET-MP may serve as an objective instrument to assess patients’ ability to transfer written information on the MP into practical handling of medicines.
Annals of Pharmacotherapy | 2006
Christiane Eickhoff; Martin Schulz
International Journal of Clinical Pharmacy | 2013
Andrea Nicolas; Christiane Eickhoff; Nina Griese; Martin Schulz
Pharmaceutical Research | 1999
Charlotte Kloft; Christiane Eickhoff; Kai Schulze-Forster; Maurer Hr; Walter Schunack; Ulrich Jaehde
European Journal of Clinical Pharmacology | 2016
Lea Botermann; Katharina Monzel; Katrin Krueger; Christiane Eickhoff; Angelika Wachter; Charlotte Kloft; Ulrich Laufs; Martin Schulz
Pharmazeutische Zeitung | 2009
Christiane Eickhoff; Nina Griese; Andrea Hämmerlein; Martin Schulz
Pharmazeutische Zeitung | 2004
Christiane Eickhoff; Manfred KRüGER; Karin Berger; Martin Schulz